Emerging ‘Dinga Dinga’ Virus Affects Over 300 in Uganda
A mysterious illness known as Dinga Dinga has emerged in Uganda’s Bundibugyo district, affecting over 300 individuals, primarily women and girls. Symptoms include fever and uncontrollable shaking, severely impacting mobility. Local health officials are monitoring the outbreak, urging residents to seek medical treatment instead of relying on unverified herbal remedies. As the Ugandan health ministry collaborates with local workers to address this health crisis, public health campaigns are underway to educate the community about the illness and its symptoms.
Uganda Receives WHO Donation of Diagnostic Kits to Combat Mpox Outbreak
The Ugandan Ministry of Health has received a vital donation of mpox diagnostic kits valued at USD 15,135 from the World Health Organization and the Federal Republic of Germany. This support enhances Uganda’s capacity for timely testing and treatment amidst an ongoing mpox outbreak, which has reported 25 confirmed cases. Health officials emphasize the importance of these kits in controlling the virus’s spread and protecting public health.
Long-Acting Injectables Transform HIV Prevention and Treatment
Long-acting injectable medications are transforming HIV prevention and treatment, offering a significant alternative to daily pills. Approved by the EMA and FDA, these injectables like cabotegravir and rilpivirine provide convenient dosing options for individuals at risk or living with HIV, enhancing adherence and reducing stigma. Discover how these innovative therapies are paving the way for improved health outcomes in the fight against HIV.
Uganda to Switch to New Malaria Vaccine for Children Under Five
Uganda is set to abandon the use of the first malaria vaccine, RTS,S (Mosquirix), in favor of the recently approved R21/Matrix-M vaccine for the immunization of children under five years old. The decision comes after the Health Ministry Division of Malaria Control revealed the country’s plan to initiate malaria vaccinations for young children starting in October. Learn more about Uganda’s switch to the R21/Matrix-M vaccine and its implications for combating malaria in the region.